NASDAQ Gain Momentum on Heightened News (MELA, PSTI, PPHM, VPHM, PACB)

New York, NY -- (SBWIRE) -- 01/15/2013 -- MELA Sciences, Inc. (NASDAQ:MELA) The company announced that it will be participating in the upcoming Needham Growth Conference, being held January 15 – 17, 2013 at the Palace Hotel in New York. Joseph V. Gulfo, MD, MELA Sciences President and CEO will be presenting at the conference on Jan. 16th. Trading at the current high of day of $2.14 (+5.94%) with over 600,000 shares that have exchanged hands, will MELA continue to push? Stick around.

Pluristem Therapeutics Inc. (NASDAQ:PSTI) Pluristem Therapeutics Inc. is bullish this morning due to the Paul-Ehrlich-Institute (PEI), the medical regulatory body for biological medicinal products for the Federal Republic of Germany, has approved the company's request to initiate a Phase II study using PLX-PAD cells in patients suffering from Intermittent Claudication (IC). Trading at an intraday of $3.51 (+8.62%) with over 600,000 shares exchanged, will PSTI push back? Stick around.

Peregrine Pharmaceuticals (NASDAQ:PPHM) Peregrine Pharmaceuticals is following recent bullish momentum, trading at an intraday of $2.20 (+5%) with over 1.7 million shares traded, will PPHM continue to push towards the end of day? Stick around.

Viropharma Inc (NASDAQ:VPHM) Viropharma Inc. surged this morning on early trading, trading at an intraday of $26 (+6.47%) with over 500,000 shares that have exchanged hands, will VPHM continue to push? Stick around.

Pacific Biosciences of California (NASDAQ:PACB) The company announced that it will hold its quarterly conference call to discuss Q4 2012 financial results on Feb. 5th, 2013. Trading at an intraday of $2.79 (+5.68%) with over 400,000 shares exchanged, will PACB continue to rally towards early February? Stick around.

View Full NASDAQ Report: http://toonicestocks.com/news/2820-nasdaq-gain-momentum-heightened-news-mela-psti-pphm-vphm-pacb

About TooNiceStocks.com
Sign up now for free weekly technical and research reports. Read our daily popular speaking research blogs. We work hard in researching companies in all exchanges. Please add us on Twitter http://www.twitter.com/toonicestocks or like us on

Facebook http://www.facebook.com/pages/TooNiceStocks/243228112357605?ref=ts Real Research for Real Investors.

None of the companies mentioned by TooNiceStocks.com in our daily market research blogs, constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. TooNiceStocks.com in no way has been compensated for advertising, marketing or profiling any of these companies, rather we have initiated our own independent research. The data stated in our research blog is derived from publicly disseminated information. Examples presented on TooNiceStocks.com website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments as these are our own opinions. Please note well that TooNiceStocks.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever.